The A to I editing landscape in melanoma and its relation to clinical outcome
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The A to I editing landscape in melanoma and its relation to clinical outcome
Authors
Keywords
-
Journal
RNA Biology
Volume 19, Issue 1, Pages 996-1006
Publisher
Informa UK Limited
Online
2022-08-22
DOI
10.1080/15476286.2022.2110390
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The BTB transcription factors ZBTB11 and ZFP131 maintain pluripotency by repressing pro-differentiation genes
- (2022) Görkem Garipler et al. Cell Reports
- Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition
- (2021) Kevin Litchfield et al. CELL
- CDK4/6 Inhibitors in Melanoma: A Comprehensive Review
- (2021) Mattia Garutti et al. Cells
- Update on tolerability and overall survival in COLUMBUS: landmark analysis of a randomised phase 3 trial of encorafenib plus binimetinib vs vemurafenib or encorafenib in patients with BRAF V600–mutant melanoma
- (2020) Paolo A. Ascierto et al. EUROPEAN JOURNAL OF CANCER
- Quantifying RNA Editing in Deep Transcriptome Datasets
- (2020) Claudio Lo Giudice et al. Frontiers in Genetics
- Targeted Therapy in Melanoma and Mechanisms of Resistance
- (2020) Anna M. Czarnecka et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- RNA binding RING E3-ligase DZIP3/hRUL138 stabilizes Cyclin D1 to drive cell cycle and cancer progression
- (2020) Srinivasa P. Kolapalli et al. CANCER RESEARCH
- Overcoming Immune Evasion in Melanoma
- (2020) Kevinn Eddy et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeted genomic profiling of acral melanoma
- (2019) Iwei Yeh et al. JNCI-Journal of the National Cancer Institute
- Early Detection of Acral Melanoma: A Review of Clinical, Dermoscopic, Histopathologic, and Molecular Characteristics
- (2019) Claudia C. Darmawan et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Many ways to resistance: How melanoma cells evade targeted therapies
- (2019) Ines Kozar et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- RNA Editing by ADAR Adenosine Deaminases: From Molecular Plasticity of Neural Proteins to the Mechanisms of Human Cancer
- (2019) A. O. Goncharov et al. BIOCHEMISTRY-MOSCOW
- NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls
- (2019) James P. Solomon et al. MODERN PATHOLOGY
- Genome-wide quantification of ADAR adenosine-to-inosine RNA editing activity
- (2019) Shalom Hillel Roth et al. NATURE METHODS
- Principles of Targeted Therapy for Melanoma
- (2019) James Sun et al. SURGICAL CLINICS OF NORTH AMERICA
- Primary and Metastatic Melanoma With NTRK Fusions
- (2018) Cecilia Lezcano et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- OUP accepted manuscript
- (2018) BIOINFORMATICS
- A-to-I miR-378a-3p editing can prevent melanoma progression via regulation of PARVA expression
- (2018) Guermarie Velazquez-Torres et al. Nature Communications
- RNA editing derived epitopes function as cancer antigens to elicit immune responses
- (2018) Minying Zhang et al. Nature Communications
- bFGF-mediated pluripotency maintenance in human induced pluripotent stem cells is associated with NRAS-MAPK signaling
- (2018) Fereshteh Haghighi et al. Cell Communication and Signaling
- Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade
- (2018) Jeffrey J. Ishizuka et al. NATURE
- The Role of RNA Editing in Cancer Development and Metabolic Disorders
- (2018) Che-Pei Kung et al. Frontiers in Endocrinology
- Salmon provides fast and bias-aware quantification of transcript expression
- (2017) Rob Patro et al. NATURE METHODS
- ADAR-Mediated RNA Editing Predicts Progression and Prognosis of Gastric Cancer
- (2016) Tim Hon Man Chan et al. GASTROENTEROLOGY
- ADAR2 functions as a tumor suppressor via editing IGFBP7 in esophageal squamous cell carcinoma
- (2016) Yuan-Bin Chen et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- REDIportal: a comprehensive database of A-to-I RNA editing events in humans
- (2016) Ernesto Picardi et al. NUCLEIC ACIDS RESEARCH
- The mRNA-edited form of GABRA3 suppresses GABRA3-mediated Akt activation and breast cancer metastasis
- (2016) Kiranmai Gumireddy et al. Nature Communications
- Altered RNA editing in 3′ UTR perturbs microRNA-mediated regulation of oncogenes and tumor-suppressors
- (2016) Liye Zhang et al. Scientific Reports
- RNA editing of non-coding RNA and its role in gene regulation
- (2015) Chammiran Daniel et al. BIOCHIMIE
- The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers
- (2015) Leng Han et al. CANCER CELL
- A new live-cell biobank workflow efficiently recovers heterogeneous melanoma cells from native biopsies
- (2015) Marieke I. G. Raaijmakers et al. EXPERIMENTAL DERMATOLOGY
- Novel CARM1-Interacting Protein, DZIP3, Is a Transcriptional Coactivator of Estrogen Receptor-α
- (2015) Daniel J. Purcell et al. MOLECULAR ENDOCRINOLOGY
- Reduced adenosine-to-inosine miR-455-5p editing promotes melanoma growth and metastasis
- (2015) Einav Shoshan et al. NATURE CELL BIOLOGY
- Activating MET kinase rearrangements in melanoma and Spitz tumours
- (2015) Iwei Yeh et al. Nature Communications
- ERBB activation modulates sensitivity to MEK1/2 inhibition in a subset of driver-negative melanoma
- (2015) Katherine E. Hutchinson et al. Oncotarget
- Profiling RNA editing in human tissues: towards the inosinome Atlas
- (2015) Ernesto Picardi et al. Scientific Reports
- Elevated RNA Editing Activity Is a Major Contributor to Transcriptomic Diversity in Tumors
- (2015) Nurit Paz-Yaacov et al. Cell Reports
- RNA editing inRHOQpromotes invasion potential in colorectal cancer
- (2014) Sae-Won Han et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Combined Vemurafenib and Cobimetinib in BRAF-Mutated Melanoma
- (2014) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Loss ofCDKN2Aexpression is a frequent event in primary invasive melanoma and correlates with sensitivity to the CDK4/6 inhibitor PD0332991 in melanoma cell lines
- (2014) Richard J. Young et al. Pigment Cell & Melanoma Research
- Kinase fusions are frequent in Spitz tumours and spitzoid melanomas
- (2014) Thomas Wiesner et al. Nature Communications
- The RNA-Editing Enzyme ADAR1 Controls Innate Immune Responses to RNA
- (2014) Niamh M. Mannion et al. Cell Reports
- voom: precision weights unlock linear model analysis tools for RNA-seq read counts
- (2014) Charity W Law et al. GENOME BIOLOGY
- REDItools: high-throughput RNA editing detection made easy
- (2013) Ernesto Picardi et al. BIOINFORMATICS
- MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth
- (2013) Yael Nemlich et al. JOURNAL OF CLINICAL INVESTIGATION
- Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma
- (2013) Leilei Chen et al. NATURE MEDICINE
- Spontaneous Peripheral T-cell Responses toward the Tumor-Associated Antigen Cyclin D1 in Patients with Clear Cell Renal Cell Carcinoma
- (2013) S. R. Dannenmann et al. Cancer Immunology Research
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- The BTB-ZF transcription factors
- (2012) Owen Siggs et al. CELL CYCLE
- POK/ZBTB proteins: an emerging family of proteins that regulate lymphoid development and function
- (2012) Sung-Uk Lee et al. IMMUNOLOGICAL REVIEWS
- Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR
- (2012) Anirudh Prahallad et al. NATURE
- ADAR2-editing activity inhibits glioblastoma growth through the modulation of the CDC14B/Skp2/p21/p27 axis
- (2012) F Galeano et al. ONCOGENE
- EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of BRAF -Mutant Colorectal Cancers to RAF Inhibition with Vemurafenib
- (2012) Ryan B. Corcoran et al. Cancer Discovery
- The Promyelocytic Leukemia Zinc Finger Protein: Two Decades of Molecular Oncology
- (2012) Bandar Ali Suliman et al. Frontiers in Oncology
- Overexpression of Renal Tumor Antigen Is Associated with Tumor Invasion and Poor Prognosis of Hepatocellular Carcinoma
- (2011) Hyung Jin Cha et al. ANNALS OF SURGICAL ONCOLOGY
- The multiple roles of amphiregulin in human cancer
- (2011) Benoit Busser et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Functions and regulation of the APOBEC family of proteins
- (2011) Harold C. Smith et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- RNA editing changes the lesion specificity for the DNA repair enzyme NEIL1
- (2010) J. Yeo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Proteome diversification by adenosine to inosine RNA-editing
- (2010) Dieter Pullirsch et al. RNA Biology
- A Survey of Genomic Traces Reveals a Common Sequencing Error, RNA Editing, and DNA Editing
- (2010) Alexander Wait Zaranek et al. PLoS Genetics
- Spitzoid melanoma
- (2009) Hideko Kamino CLINICS IN DERMATOLOGY
- Large-scale mRNA sequencing determines global regulation of RNA editing during brain development
- (2009) H. Wahlstedt et al. GENOME RESEARCH
- Amphiregulin Promotes BAX Inhibition and Resistance to Gefitinib in Non-small-cell Lung Cancers
- (2009) Benoît Busser et al. MOLECULAR THERAPY
- The impact of retrotransposons on human genome evolution
- (2009) Richard Cordaux et al. NATURE REVIEWS GENETICS
- Evidence for large diversity in the human transcriptome created by Alu RNA editing
- (2009) Michal Barak et al. NUCLEIC ACIDS RESEARCH
- Genome-Wide Identification of Human RNA Editing Sites by Parallel DNA Capturing and Sequencing
- (2009) J. B. Li et al. SCIENCE
- Adenosine-to-inosine RNA editing
- (2009) Boris Zinshteyn et al. Wiley Interdisciplinary Reviews-Systems Biology and Medicine
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started